Pox viridae treatment

Details Pox viridae treatment Pox viridae treatment

2011-07-12

2011-07-12

Mosher, Mary E (Department: 1648)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

C424S278100, C424S489000

Reexamination Certificate

active

07976850

ABSTRACT:
A vaccine composition for combatingPox viridaeviral infections in living organisms such as mammals (including humans) comprises TAP-1 and/or TAP-2 to augment the antigen processing capability of infected cells and hence their immunogenicity. The composition may be used alone or, preferably, as an immunogenicity-enhancing adjuvant with a pox antigen-based vaccine, especially in the treatment or prophylaxis of viral infections such as smallpox.

REFERENCES:
patent: 4399216 (1983-08-01), Axel et al.
patent: 4704362 (1987-11-01), Itakura et al.
patent: 4766950 (1988-08-01), Yamada et al.
patent: 4784950 (1988-11-01), Hagen et al.
patent: 4801542 (1989-01-01), Murray et al.
patent: 4935349 (1990-06-01), McKnight et al.
patent: 5034506 (1991-07-01), Summerton et al.
patent: 5843456 (1998-12-01), Paoletti et al.
patent: 2003/0082195 (2003-05-01), Jefferies et al.
patent: W09204033 (1992-03-01), None
patent: WO 2004/112706 (2004-12-01), None
Vitalis et al (PLOS Pathogens 1(4) e36, Dec. 2005).
Deverson, E. V. et al., “MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters”, Nature Dec. 20-27, 1990; 348(6303): 674-5—Abstract.
Trowsdale, J. et al., “Sequence encoded in the class II region of the MHC related to the ‘ABC’ superfamily of transporters”, Nature Dec. 20-27, 1990, 348(6303):674-5—Abstract.

Affiliated with

Also associated with

Rating

Pox viridae treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pox viridae treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pox viridae treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2730402